This is the authors' abstract. We don't add key points for this paper.
The induction of donor-specific immune tolerance is the "holy grail" of transplantation, as it would avoid the toxicities of chronic immunosuppressive therapies while preventing acute and chronic graft rejection. A large number of approaches to tolerance induction have been described in the experimental literature, but only hematopoietic cell transplantation has shown preliminary success for intentional tolerance induction in pilot clinical trials. This review summarizes the conditions that allow progress to be made in moving strategies for tolerance induction from the bench to the bedside and discuss the mechanisms by which tolerance may be achieved through hematopoietic cell transplantation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Megan Sykes (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: